Surgery Partners Inc (NASDAQ:SGRY) has earned a consensus recommendation of “Hold” from the eight ratings firms that are covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $18.75.
Several analysts have recently issued reports on SGRY shares. BidaskClub raised Surgery Partners from a “hold” rating to a “buy” rating in a report on Thursday, February 7th. Zacks Investment Research raised Surgery Partners from a “sell” rating to a “hold” rating in a report on Wednesday, January 9th. Finally, ValuEngine lowered Surgery Partners from a “buy” rating to a “hold” rating in a report on Thursday, February 7th.
Shares of SGRY traded down $0.05 during trading hours on Monday, hitting $11.25. 157,373 shares of the company were exchanged, compared to its average volume of 232,552. The firm has a market cap of $570.49 million, a P/E ratio of -4.59 and a beta of 2.56. Surgery Partners has a fifty-two week low of $9.45 and a fifty-two week high of $19.95. The company has a debt-to-equity ratio of 2.07, a quick ratio of 1.56 and a current ratio of 1.68.
Surgery Partners (NASDAQ:SGRY) last released its earnings results on Wednesday, March 13th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.75). The company had revenue of $491.20 million for the quarter, compared to analyst estimates of $485.35 million. Surgery Partners had a negative return on equity of 3.90% and a negative net margin of 11.45%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the company posted ($0.03) earnings per share. On average, research analysts predict that Surgery Partners will post -0.77 earnings per share for the current fiscal year.
A number of large investors have recently added to or reduced their stakes in SGRY. Renaissance Technologies LLC acquired a new stake in Surgery Partners in the third quarter valued at about $3,835,000. BlackRock Inc. boosted its stake in Surgery Partners by 16.9% in the fourth quarter. BlackRock Inc. now owns 1,452,957 shares of the company’s stock valued at $14,225,000 after buying an additional 209,539 shares in the last quarter. Elk Creek Partners LLC boosted its stake in Surgery Partners by 17.9% in the fourth quarter. Elk Creek Partners LLC now owns 1,303,594 shares of the company’s stock valued at $12,762,000 after buying an additional 197,872 shares in the last quarter. Millennium Management LLC acquired a new stake in Surgery Partners in the fourth quarter valued at about $1,595,000. Finally, Clearbridge Investments LLC boosted its stake in Surgery Partners by 4.6% in the third quarter. Clearbridge Investments LLC now owns 3,250,407 shares of the company’s stock valued at $53,632,000 after buying an additional 143,561 shares in the last quarter. 97.48% of the stock is currently owned by institutional investors and hedge funds.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Recommended Story: What is the Rule of 72?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.